微循环学杂志
微循環學雜誌
미순배학잡지
CHINESE JOURNAL OF MICROCIRCULATION
2014年
4期
35-39
,共5页
潘小平%洪晓绿%吴锋%赖金国%姚明媚%江文力%邓英钊
潘小平%洪曉綠%吳鋒%賴金國%姚明媚%江文力%鄧英釗
반소평%홍효록%오봉%뢰금국%요명미%강문력%산영쇠
乳腺癌%内皮素-3%甲基化%实时定量PCR%甲基化特异性PCR
乳腺癌%內皮素-3%甲基化%實時定量PCR%甲基化特異性PCR
유선암%내피소-3%갑기화%실시정량PCR%갑기화특이성PCR
Breast carcinoma%Endothelin-3%Methylation%Real-time quantitative PCR%Methylation-specific PCR
目的:检测分析内皮素-3(EDN-3)基因表达及其启动子甲基化在乳腺癌患者各种临床状态的变化。方法:采用实时定量PCR(RT-PCR)和甲基化PCR(MS-PCR)方法检测54例乳腺癌患者(实验组)及60例体检健康女性(对照组)外周血中 EDN-3 mRNA表达及其启动子甲基化发生率,比较以上两指标变化在乳腺癌患者不同临床状态的统计学差异。结果:实验组 EDN-3 mRNA表达较对照组显著降低,差异有统计学意义(t=-7.84,P<0.01),但这种降低在患者不同年龄、不同肿瘤组织类型和大小、有否区域淋巴结转移及远处转移之间差异均无统计学意义(P>0.05)。实验组 EDN-3启动子甲基化检出率为55.56%(30/54),对照组未检出甲基化,差异有统计学意义(χ2=45.238,P<0.01);EDN-3启动子甲基化在上述不同临床状态时的差异亦无统计学意义(P>0.05)。结论:EDN-3 mRNA转录下调和启动子甲基化可能与乳腺癌的发生有关,与患者临床病理状态无关。
目的:檢測分析內皮素-3(EDN-3)基因錶達及其啟動子甲基化在乳腺癌患者各種臨床狀態的變化。方法:採用實時定量PCR(RT-PCR)和甲基化PCR(MS-PCR)方法檢測54例乳腺癌患者(實驗組)及60例體檢健康女性(對照組)外週血中 EDN-3 mRNA錶達及其啟動子甲基化髮生率,比較以上兩指標變化在乳腺癌患者不同臨床狀態的統計學差異。結果:實驗組 EDN-3 mRNA錶達較對照組顯著降低,差異有統計學意義(t=-7.84,P<0.01),但這種降低在患者不同年齡、不同腫瘤組織類型和大小、有否區域淋巴結轉移及遠處轉移之間差異均無統計學意義(P>0.05)。實驗組 EDN-3啟動子甲基化檢齣率為55.56%(30/54),對照組未檢齣甲基化,差異有統計學意義(χ2=45.238,P<0.01);EDN-3啟動子甲基化在上述不同臨床狀態時的差異亦無統計學意義(P>0.05)。結論:EDN-3 mRNA轉錄下調和啟動子甲基化可能與乳腺癌的髮生有關,與患者臨床病理狀態無關。
목적:검측분석내피소-3(EDN-3)기인표체급기계동자갑기화재유선암환자각충림상상태적변화。방법:채용실시정량PCR(RT-PCR)화갑기화PCR(MS-PCR)방법검측54례유선암환자(실험조)급60례체검건강녀성(대조조)외주혈중 EDN-3 mRNA표체급기계동자갑기화발생솔,비교이상량지표변화재유선암환자불동림상상태적통계학차이。결과:실험조 EDN-3 mRNA표체교대조조현저강저,차이유통계학의의(t=-7.84,P<0.01),단저충강저재환자불동년령、불동종류조직류형화대소、유부구역림파결전이급원처전이지간차이균무통계학의의(P>0.05)。실험조 EDN-3계동자갑기화검출솔위55.56%(30/54),대조조미검출갑기화,차이유통계학의의(χ2=45.238,P<0.01);EDN-3계동자갑기화재상술불동림상상태시적차이역무통계학의의(P>0.05)。결론:EDN-3 mRNA전록하조화계동자갑기화가능여유선암적발생유관,여환자림상병리상태무관。
Objective:To investigate the mRNA expression and the incidence rate of methylation of endothelin-3 (EDN-3)promoter in patients with breast carcinoma in different clinical features.Method:The mRNA expreesi-on and methylation of EDN-3 gene in 54 patients with breast carcinoma (experimental group)and 60 healthy women (control group)were assessed with real-time quantitative polymerase chain reaction (RT-PCR)and methylation-spe-cific polymerase chain reaction (MS-PCR),respectively.The two index above between these gentic features and clinical features were analyzed.Results:The expression of EDN-3 mRNA was significantly lower in experimental group than that of control group (t=-7.84,P<0.01).However there were no significantly differences in different clinical features including the age of patients,tumor tissue type and tumor size,lymph node metastasis and distant metastasis (P>0.05).The detection rate of methylation of EDN-3 promoter was 55.56% (30/54)in experimental group,while the control group was not detected abnormal methylation samples,there were significantly differences between experimental group and control group(χ2=45.238,P<0.01),but there were also no differences among all the clinical fea-tures (P>0.05).Conclusion:The down-regulation of transcription of EDN-3 mRNA and the methylation of EDN-3 pro-moter might be related with the occurrence of breast cancer,but there were no differences among all the clinical features.